Accelerate to discover

Back to filter

Related topics

Cytek webinar: Imaging Flow Cytometry for Chromosomal Assessment in Hematological Malignancies

Cytek Biosciences

Jun 7, 2024

In this webinar, we will describe a new innovative approach we developed that resolves these limitations. The method...

Hypoxia in the Tumor Immune Microenvironment (TIME)

Bruker Biospin

Jun 6, 2024

Thursday, 11 July 2024, 16:00 CET | 10:00 EST
Zaver M. Bhujwalla, PhD...

X-RAD 320 for irradiation therapy during quantifying study for in vivo collagen reorganization

Precision X-Ray

Jun 5, 2024

Quantifying in vivo collagen reorganization during immunotherapy in murine melanoma with second harmonic generation...

Use of MRI and microCT to evaluate gene therapy for the treatment of discogenic back pain

Bruker Biospin

Jun 4, 2024

MRI images were obtained using the 9.4T Bruker BioSpec system, equipped with 40 mm 1H quadrature volume resonator, and...

Jun 18, 2024

Exosome-Mediated Delivery of Small Molecules, RNA & DNA for Development of Novel Cancer Therapeutics

Spectral Instruments Imaging

Jun 3, 2024

Disha Moholkar of University of Louisville's Gupta Lab
Tuesday, June 11, 2024, 6:30 PM
...

Emulate in vivo conditions – introduce shear flow to your experiments with BioFlux system

Cell Microsystems

May 27, 2024

Most research is still conducted in vitro without the presence of flow. We use the BioFlux System to give you the...

High-frequency Ultrasound System For Preclinical Imaging

S-Sharp

May 13, 2024

The Prospect T1 is an innovative high-frequency ultrasound system designed specifically for in vivo preclinical imaging...

Jun 18, 2024

Automatically Acquire Bioluminescent Kinetic Curve Data in Real Time

Spectral Instruments Imaging

May 10, 2024

New Kinetics Mode of Aura software ensures you're capturing peak data for optimal sensitivity & reproducibility

Show all topics (10)

Intelligent antibody discovery

Apr 4, 2016

With the promise of better specificity and safety, antibody-based drugs are a powerful tool for treating disease. But finding the best candidates to move through development can be time consuming and expensive. It’s not just about screening to find the highest-affinity binder, it’s also about finding the antibody that can promote the desired biological response while avoiding off-target binding and toxicity.

The iQue Screener speeds your antibody discovery programs by reducing screening time while increasing the amount and kind of data you can collect. In just a fraction of the time it takes to do a high-throughput ELISA—and using far less target protein—the iQue Screener not only provides quantitative binding information, it can also deliver data from cell-based assays that report on functions such as membrane integrity, cytokine release, and more. This comprehensive data set helps you make more informed decisions about potential leads faster, reducing discovery time, reducing discovery costs, and conserving valuable reagents.

Application
Product news

Related technologies: Conventional flow cytometry | HTP Screening

Brand profile

IntelliCyt

IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey